University of Texas at Arlington since Sep 2007
Research Assistant
Sinosoft Co. Ltd. Feb 2005 - Jul 2007
Sr. Software Engineer, Project manager
Beijing Kop Co. Ltd. Feb 2002 - Jan 2005
Chief Technical Officer
Bright Ocean Software Research Institute Jul 1997 - Feb 2002
Software Engineer, Project Manager
Education:
The University of Texas at Arlington 2007 - 2011
phd, Computer Science
University of Science and Technology of China 2000 - 2003
Master, Computer Science
Shenyang Jianzhu University 1993 - 1997
Bachelor, Computer Engineering
Skills:
Android Java Computer Science Programming Telecommunications C++ Mysql Eclipse C Linux C# Jsp Software Development Unix Visual Studio Xml Data Mining Javascript Sql Databases Html J2Ee
Sep 2008 to 2000 Independent Contractor: Marketing Manager/Brand AmbassadorKing Wah Chop Suey Restaurant Detroit, MI Aug 2002 to Aug 2008 Assistant ManagerCarter-Culp and Associates Troy, MI Aug 2000 to Jul 2002 Sales Analyst
Education:
University of Michigan-Dearborn Dearborn, MI Sep 1995 to Dec 1999 Bachelor of Business Administration in Management and Management Information Systems
Medicine Doctors
Dr. Yong S Lin, New York NY - MD (Doctor of Medicine)
Yong S Lin MD 217 Grand St STE 301, New York, NY 10013 2122269717 (phone), 2122269723 (fax)
Education:
Medical School Southeast Univ Med Coll, Nanjing, Jiangsu, China Graduated: 1984
Procedures:
Electrocardiogram (EKG or ECG) Nutrition Therapy Pulmonary Function Tests Vaccine Administration
Conditions:
Acne Acute Upper Respiratory Tract Infections Atopic Dermatitis Benign Prostatic Hypertrophy Calculus of the Urinary System
Languages:
Chinese English
Description:
Dr. Lin graduated from the Southeast Univ Med Coll, Nanjing, Jiangsu, China in 1984. He works in New York, NY and specializes in Internal Medicine. Dr. Lin is affiliated with New York Presbyterian Lower Manhattan Hospital.
Cedars-Sinai Medical Center Pain Center 444 S San Vicente Blvd STE 1101, Los Angeles, CA 90048 3104239600 (phone), 3104239610 (fax)
Education:
Medical School Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) Graduated: 1982
Languages:
English
Description:
Dr. Lin graduated from the Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) in 1982. He works in Los Angeles, CA and specializes in Anesthesiology. Dr. Lin is affiliated with Cedars-Sinai Medical Center.
Gerard M. Turino - New York NY, US Yong Y. Lin - Bridgewater NJ, US Shuren Ma - Cliffside Park NJ, US Seymour Lieberman - New York NY, US
International Classification:
C12Q 1/68 C12Q 1/00 G01N 33/00 C12Q 1/02
US Classification:
435 6, 435 4, 436 96, 435 29
Abstract:
The present invention relates to methods of diagnosing and treating elastin fiber injuries. In additional preferred embodiments, the present invention relates to methods of validating candidate compounds for use in treating chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, refractory asthma, and other related diseases. Examples of such methods include determining if the candidate compound decreases the degradation of elastic fiber in a patient administered the candidate compound by measuring, using mass spectrometry, a marker of elastic fiber degradation in a sample of a body fluid or a tissue of the patient. The invention provides that a decrease in the presence of the marker compared to a control validates that the candidate compound is effective to treat, prevent, or ameliorate the disease.
Peter H. SCHAFER - Somerset NJ, US Yong Lin - Brooklyn NY, US Donna Sutherland - Green Brook NJ, US
International Classification:
C12Q 1/68 G01N 33/566
US Classification:
435 611, 435 721, 435 724, 435 613, 435 612
Abstract:
Provided herein are the biomarkers for predicting or monitoring the efficacy of a treatment for psoriasis. The use of certain cell markers and mRNA levels as biomarkers to predict whether a psoriasis treatment is likely to be successful is also provided. Further, the expression of these genes or cell markers can be used to monitor progress of treatment effectiveness and patient compliance in psoriasis patients who are receiving treatment.
Methods Of Validating Candidate Compounds For Use In Treating Copd And Other Diseases
Shuren Ma - Cliffside Park NJ, US Yong Y. Lin - Bridgewater NJ, US Seymour Leiberman - New York NY, US
International Classification:
G01N 27/62
US Classification:
435 23, 436 96, 435 29
Abstract:
The present invention relates to methods of diagnosing, monitoring, and treating elastin fiber injuries. In additional preferred embodiments, the present invention relates to methods of validating candidate compounds for use in treating chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, refractory asthma, and other related diseases. Examples of such methods include determining if the candidate compound decreases the degradation of elastic fiber in a patient administered the candidate compound by measuring, using mass spectrometry employing an internal standard, a marker of elastic fiber degradation in a sample of a body fluid or a tissue of the patient. The invention provides that a decrease in the presence of the marker compared to a control validates that the candidate compound is effective to treat, prevent, or ameliorate the disease.
Packaged Semiconductor Device Having Nanoparticle Adhesion Layer Patterned Into Zones Of Electrical Conductance And Insulation
A device comprises a substrate and an adhesive nanoparticle layer patterned into zones of electrical conductance and insulation on top of the substrate surface. A diffusion region adjoining the surface comprises an admixture of the nanoparticles in the substrate material. When the nanoparticle layer is patterned from originally all-conductive nanoparticles, the insulating zones are created by selective oxidation; when the nanoparticle layer is patterned from originally all-non-conductive nanoparticles, the conductive zones are created by depositing selectively a volatile reducing agent. A package of insulating material is in touch with the nanoparticle layer and fills any voids in the nanoparticle layer.
Packaged Semiconductor Device Having Nanoparticle Adhesion Layer Patterned Into Zones Of Electrical Conductance And Insulation
A device comprises a substrate and an adhesive nanoparticle layer patterned into zones of electrical conductance and insulation on top of the substrate surface. A diffusion region adjoining the surface comprises an admixture of the nanoparticles in the substrate material. When the nanoparticle layer is patterned from originally all-conductive nanoparticles, the insulating zones are created by selective oxidation; when the nanoparticle layer is patterned from originally all-non-conductive nanoparticles, the conductive zones are created by depositing selectively a volatile reducing agent. A package of insulating material is in touch with the nanoparticle layer and fills any voids in the nanoparticle layer.
Methods Of Validating Candidate Compounds For Use In Treating Copd And Other Diseases
- New York NY, US Shuren Ma - Cliffside Park NJ, US Yong Y. Lin - Bridgewater NJ, US Seymour Leiberman - , US
International Classification:
G01N 33/68 H01J 49/00 G01N 27/62 G01N 30/72
Abstract:
The present invention relates to methods of diagnosing, monitoring, and treating elastin fiber injuries. In additional preferred embodiments, the present invention relates to methods of validating candidate compounds for use in treating chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, refractory asthma, and other related diseases. Examples of such methods include determining if the candidate compound decreases the degradation of elastic fiber in a patient administered the candidate compound by measuring, using mass spectrometry employing an internal standard, a marker of elastic fiber degradation in a sample of a body fluid or a tissue of the patient. The invention provides that a decrease in the presence of the marker compared to a control validates that the candidate compound is effective to treat, prevent, or ameliorate the disease.
Methods Of Validating Candidate Compounds For Use In Treating Copd And Other Diseases
- New York NY, US Shuren Ma - Cliffside Park NJ, US Yong Y Lin - Bridgewater NJ, US Seymour Leiberman - , US
International Classification:
G01N 33/68 G01N 30/72 H01J 49/00
Abstract:
The present invention relates to methods of diagnosing, monitoring, and treating elastin fiber injuries. In additional preferred embodiments, the present invention relates to methods of validating candidate compounds for use in treating chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, refractory asthma, and other related diseases. Examples of such methods include determining if the candidate compound decreases the degradation of elastic fiber in a patient administered the candidate compound by measuring, using mass spectrometry employing an internal standard, a marker of elastic fiber degradation in a sample of a body fluid or a tissue of the patient. The invention provides that a decrease in the presence of the marker compared to a control validates that the candidate compound is effective to treat, prevent, or ameliorate the disease.
handran, other investigators include: Christine Ambrosone, Gary Zirpoli, Gregory Ciupak, Susan E. McCann, and Zhihong Gong, Roswell Park Cancer Institute; Karen Pawlish, New Jersey State Cancer Registry; and Yong Lin and Kitaw Demissie, The Cancer Institute of New Jersey and UMDNJ-School of Public Health.